Tension-type headache Comorbidities EHF-summerschool Belgrade May 2012

Similar documents
Epidemiology and Burden of Headache

An Overview of MOH. ALAN M. Rapoport, M.D. Clinical Professor of Neurology The David Geffen School of Medicine at UCLA Los Angeles, California

Aleksandra Radojičić. Headache Center, Neurology Clinic, Clinical Center of Serbia

Specific Objectives A. Topics to be lectured and discussed at the plenary sessions

Treatment Of Medication. Overuse Headache

UCNS Course A Review of ICHD-3b

ปวดศ รษะมา 5 ป ก นยาแก ปวดก ย งไม ข น นพ.พาว ฒ เมฆว ช ย โรงพยาบาลนครราชส มา

Chronic Daily Headaches

Recognition and treatment of medication overuse headache

By Nathan Hall Associate Editor

Medication overuse headache is a severe chronic pain condition that is preventable and treatable. An International Experience

Disclosures. Objectives 6/2/2017

Headache Master School Japan-Osaka 2016 (HMSJ-Osaka2016) October 23, II. Management of Refractory Headaches

A case of a patient with chronic headache. Focus on Migraine. None related to the presentation Grants to conduct clinical trials from: Speaker bureau:

Stuart Weatherby Consultant Neurologist Derriford Hospital. Plymouth

The epidemiology of headache disorders: a face-to-face interview of participants in HUNT4

Çiçek Wöber-Bingöl HEADACHE UNIT FOR CHILDREN AND ADOLESCENCE

A synopsis of: Diagnosis and Management of Headaches in Adults: A national clinical guideline. Scottish intercollegiate Guidelines Network SIGN

HEADACHE: Benign or Severe Dr Gobinda Chandra Roy

Study No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:

Comorbidities of Migraine

Chronic Migraine in Primary Care. December 11 th, 2017 Werner J. Becker University of Calgary

RISK FACTORS AND PROGNOSIS OF CHRONIC MIGRAINE

Signe B Munksgaard, Lars Bendtsen and Rigmor H Jensen. Introduction. Original Article

The best defense is a good offense. Optimizing the Acute Treatment of Migraine. Disclosures 11/10/2017

Measure Components Numerator Statement

Classification of headaches

GENERAL APPROACH AND CLASSIFICATION OF HEADACHES

Prednisone vs. placebo in withdrawal therapy following medication overuse headache

Management of headache

Conflicts of interest statements

Medication overuse headache: a critical review of end points in recent follow-up studies

Multidisciplinary team approach to headache care

Headache. Luke Bennetto Consultant Neurologist Engineers House 13 th September 2016

Clinical case. Clinical case 3/15/2018 OVERVIEW. Refractory headaches and update on novel treatment. Refractory headache.

Trigeminal Autonomic Cephalalgias. Disclosures. Objectives 6/20/2018. Rashmi Halker Singh, MD FAHS UCNS Review Course June 2018

HEADACHES THE RED FLAGS

Faculty Disclosures. Learning Objectives. Acute Treatment Strategies

MEASURE #4: Overuse of Barbiturate Containing Medications for Primary Headache Disorders Headache

Application of ICHD 2nd edition criteria for primary headaches with the aid of a computerised, structured medical record for the specialist

Managing Headache in Acute Medicine. Ben Lovell Consultant Physician in Acute Medicine University College London Hospital

Headaches in Children and Adolescents. Paul Shillito

Migraine much more than just a headache

MIGRAINE ASSOCIATION OF IRELAND

OCTOBER 7-10 PHILADELPHIA, PENNSYLVANIA

Classification of headaches

Controversy One: Headache and Disability. Robert Shapiro, MD, PhD University of Vermont

Prevalence of primary headaches in Germany: results of the German Headache Consortium Study

Tension Type Headache and Percieved Stress Level: A Correlational Study

Cluster headache (CH): epidemiology, classification and clinical picture

Headaches. Mini Medical School. November 10, A. Laine Green MSc, MD FRCP(C) Assistant Professor Department of Medicine (Neurology)

Jessica Ailani MD FAHS Director, Georgetown Headache Center Associate Professor Neurology Medstar Georgetown University Hospital

Ishaq Abu Arafeh Consultant Paediatrician Royal Hospital for Children, Glasgow Forth Valley Royal Hospital, Larbert

NIH Public Access Author Manuscript Curr Pain Headache Rep. Author manuscript; available in PMC 2014 May 22.

Classification and WHO ICD-10NA Codes

Risk Factors, Clinical Course, and Barriers to Care in Adults and Pediatrics. Rebecca R. Buttaccio, PA-C Dent Neurologic Institute

Tears of Pain SUNCT and SUNA A/PROFESSOR ARUN AGGARWAL RPAH PAIN MANAGEMENT CENTRE

6/2/2017. Objectives. Statement of Problem: Migraine Headaches Are Common. Chronic Headache In Pediatrics, Botox and Beyond

Tension-type Headaches

Does repeated subcutaneous administration of sumatriptan produce an unfavorable evolution in cluster headache?

Disclosures. Triptans for Kids 5/16/13

I have no financial relationships to disclose. I will not discuss investigational use of medication in my presentation.

Migraine Types and Triggering Factors in Children

Current Migraine Treatment Therapy. Daniel Kassicieh, DO, FAAN

Headache Mary D. Hughes, MD Neuroscience Associates

Headache Master School Japan-Osaka 2016 II. Management of refractory headaches Case Presentation 2. SUNCT/SUNA: concept, management and prognosis

Headache Pain Generators

The validity of questionnaire-based diagnoses: the third Nord-Trøndelag Health Study

Learning objectives 6/20/2018

FINANCIAL DISCLOSURE. No relevant financial relationships

Physiotherapy for tension-type headache: a controlled study

Nee Kong CHEW, Chong Tin TAN, Heng Thay CHONG, Yau Hoong CHAN, Kuoh Ren CHONG, Hee Hong LAM, Yan Beng NGE, Chek Tung NGO.

Painless, progressive weakness Could this be Motor Neurone Disease?

HEADACHES AND MIGRAINES

Specific features of migraine syndrome in children

Web: Medication overuse headache and undergoing a detox programme

10/17/2017 CHRONIC MIGRAINES BOTOX: TO INJECT OR NOT INJECT? IN CHRONIC MIGRAINE PROPHYLAXIS OBJECTIVES PATIENT CASE EPIDEMIOLOGY EPIDEMIOLOGY

Refractory Headache Challenges and Strategies. David W. Dodick, M.D. Department of Neurology Mayo Clinic Phoenix Arizona USA

Insomnia. F r e q u e n t l y A s k e d Q u e s t i o n s

Caspian Journal of Neurological Sciences "Caspian J Neurol Sci" Journal Homepage:

Sleep History Questionnaire

florida child neurology

Corporate Medical Policy

Title: Diagnosing migraine in research and clinical settings: The Validation of the Structured Migraine Interview (SMI)

Welcome to the program!

Update on Diagnosis and Management of Migraines

Basal cutaneous pain threshold in headache patients

Get ahead of the ACHE: Monoclonal Antibodies in Migraine Prevention

Overuse of barbiturate and opioid containing medications for primary headache disorders Description

Migraine Diagnosis and Treatment: Results From the American Migraine Study II

Differentiating Migraine from Other Headache Types to Target Treatment Peter J. Goadsby, MD, PhD

Headache Education - A Case for a Better Way! R. Allan Purdy MD, FRCPC Professor of Medicine (Neurology) Dalhousie University, Halifax, Canada

Adolescent Migraine Treatment O F A

23 How Cluster Headache and Other Trigeminal Autonomic Cephalalgias Present

Migraine strikes study: factors in patients decision to treat early

Is Yoga an Effective Treatment for Reducing the Frequency of Episodic Migraine?

Chronic migraine classification: current knowledge and future perspectives

CLUSTER HEADACHES: THE WORST PAIN POSSIBLE? QUESTIONS:

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE

A Q&A with N1-Headache users

Transcription:

Tension-type headache Comorbidities EHF-summerschool Belgrade May 2012 Conflicts of Interest: Lectures for Pfizer, Berlin-Chemie, Allergan, Merck Member of advisory boards in: ATI, Medotech, Neurocore, and Linde Gas ltd. Director in LTB, EHMTIC and Vicepresident in EHF A gift to The Danish Cluster Headache Foundation and located in the Danish Headache Centre. Painted by Maiken Hejnfeldt, a patient with chronic cluster headache for more than 20 years.

Agenda What is the problem Goals: Optimal diagnosis and treatment Obstacles: Identification and mechanisms of chronification Management Discussion

International Headache Classification, (ICHD- II) (Cephalalgia 2004; 24[Suppl 1]: 1-160) IHCD-II 14 subgroups Group 1-4 Primary headaches Group 5 12 Secondary headaches Group 13 14 Cranial neuralgias, etc Migraine, TTH, Cluster headache, Other TAC s Medication Trauma, stroke, Neoplastic and systemic disorders Trigeminal neuralgia, Other cranial neuralgia and Facial pain disorders

Natural History Remission Evolution to few or no attacks over years Headache Persistence Relative stable attack frequency Progression Evolution to chronic headache

Prevalence of Tension-Type headache in the general population (days per year) 45% 40% 35% 30% 25% 20% Males Females 15% 10% 5% 0% 0 days 1-7 days 8-14 days 15-30 days 31-100 days 101-179 days more than 180 days Lyngberg et al. Eur J Epidemiol 2005 Lifetime prevalence: 86% (98% in females and 76% in males)

Comorbidity Definition: Association with 2 or more disorders occuring together greater than chanche alone Migraine: Depression, Anxiety, CVD, Stroke, astma, raynaud, restless legs syndrome and othe rheadache disorders

Comorbidities and Differential diagnosis to Tension-Type headache Migraine A secondary headache GI problems Sleep disorder Depression Anxiety Medication-Overuse headache

Comorbidity of headache and gastrointestinal complaints Aamodt et al Cephalalgia 2008 Hypothesis? Conclusion: This may suggest that headache sufferers generally are predisposed to gastrointestinal complaints Unidirectional or bidirectional relation? GI-questionnaire? Related to other factors? Tobacco? Medication? Social factors? Education? Psychological factors? IBS? Diet?

Relation between Reflux symptoms, headache and age (Aamodt et al 2008)

Sleep disorders? Problem: Pain affect sleep /Impaired sleep induce pain Sleep apnoea 2-4% affect of the general population Morning headache? (ICHD-II) Cross sectional study in Norway 40.000 adults (Kristiansen et al JHHP 2011) Prevalence of ftth and CTTH, 18.7% and 2.1% resp in SOA persons vs 31.6% and 1.6% resp in Non-SOA persons Conclusion: No association between SOA and tension-type headache when controlled for frequency of headache Females had the headaches and men had SOA but other sleep disorders are not studied in relation to TTH

Psychological comorbidities in tensiontype headache Depression (OR 1.9-2.4) Anxiety ( OR 2-3) Neuroticism (1.0-1.8) Other? The risk for depression and anxiety increase in parallel with headache frequency in both migraine and TTH

Psychological comorbidity? Lyngberg et al (in prep) Quality of Life - psychological health Quality of Life - physical health Migraine Migraine adjusted TTH TTH adjusted p p p p 0.002 0.04 < 0.0001 0.0003 0.0005 0.06 < 0.0001 <0.0001 Depression 0.02 0.31 < 0.0001 < 0.0001 Neuroticism 0.03 0.43 < 0.0001 < 0.0001

Major depression Headache individuals from general population % Multivariat: Migraine: 10 p = 0,31 Tension-type headache: 8 p < 0,0001 6 4 5 3 5 2 0 1 Begge Migræne Sp.hvp Raske Hovedpinegruppe

Neuroticism/ depression headache individuals from general population Point 10 8 9 9 8 7 9 8 6 6 5 4 2 0 Begge Migræne Sp.hvp Raske Hovedpinegruppe

Current Pain and Headache reports 2006

"My doctor's great, but I'm just not getting better!! "He's just too busy!"

Case 44 year old lady refferred with a chronic refractory headache No familial history to headache Otherwise healthy Diagnostic strategy? Therapeutic strategy? Prognosis?

The 8 most important questions to ask a headache patient Have you one or several different types of headache? Describe them one by one How long does your headaches last? (seconds, minutes, hours, days) How frequent are your headaches? What is the intensity of pain? What do you do during a headache attack? Where is the pain located? Are there any associated symptoms? Do you take medication?

The 8 most important questions to ask a headache patient Have you one or several different types of headache? Describe them one by one How long does your headaches last? (seconds, minutes, hours, days) How frequent are your headaches? What is the intensity of pain? What do you do during a headache attack? Where is the pain located? Are there any associated symptoms? Do you take medication? One type, I think, vary in intensity Constant, all day Constant lasted for more than 40 years, started as episodic at the age of 4 Moderate to severe Try to function, but have to lie down during severe pain Holocranial No but Photophobia, phonophobia, sometimes nausea when it is severe Yes, I have to, on a daily basis

Diagnostic diary or headache calender for at least 4 weeks

TIME LINE FOR HEADACHE DURATION and MOST LIKELY DIAGNOSIS SUNCT or TN CPH Cluster Headache Migraine TTH MOH Seconds Minutes ½-3 Hours 4-72 Hours Days/weeks Months

Key points for chronification Frequent intake of pain killers and antimigraine drugs may induce medication overuse headache Sustained administration of pain killers, triptans or opiates produces neuroadaptive changes These neural adaptations might be responsible for hyperexcitability of the trigeminal system and engagement of descending facilitation Enhanced descending facilitation may manifest as loss of diffuse noxious inhibitory control De Felice et al Curr Opin Neurol 2011

Clinical features (medication overuse headache, MOH) Daily or almost daily headaches Medication overuse Dull diffuse headache With or without associated symptoms Wake up with headache Medication intake Superimposed migraine-like attacks Mon Tue Wed Thur Increased frequency of attacks

ICHD-II - Medication-Overuse Headache II revision, 2006 a system whereby medication overuse headache became a default diagnosis in all patients with medication overuse would encourage doctors all over the world to do the right thing, namely, to take patients off medication overuse as the first step in a treatment plan. A. Headache present on 15 days/month B. Regular overuse for >3 months of one or more acute/symptomatic treatment drugs as defined under sub form 8.2 1. Ergotamine, triptans, opioids or combination analgesic medications on 10 days/month on a regular basis for >3 months 2. Simple analgesics or any combination of ergotamine, triptans, analgesics, opioids on 15 days/ month on a regular basis for > 3 months without overuse of any single class alone C. Headache has developed or markedly worsened during medication overuse

Pain sensitivity during and after long term exposure to opioids or triptans 5 4 3 2 1 Opiods or triptans Repeated dose or stress 0-1 week 0 week 1 week 2 week 3 week 4 week x -2-3 -4-5 After Vera-Portocarrero LP et Porreca F 2008

Medication overuse headache Prevalence: Outcome: Treatment: Succesrate: Depression: Prognosis: after 1 year Cost-effective: 1 2% of adult population Is treatable and preventable Cessation of overuse 60 93% (Mig and triptans) but 40-45% in TTH > 50% improved after detox Good, 65 69% success Cost of triptans reduced with 68% after 1 yr Gaist et al; Katsarava et al, Zeeberg et al, Shah et al

Days/month Effect of detoxification and multidisciplinary treatment in medication overuse headache 30 25 20 Visit 1 Final visit 15 *** 10 *** 5 ***p<0.001 0 Tension-type headache Migraine Zeeberg et al 2007

Identification and outcome of MOH: A typical headache calender

Mechanisms of chronification Genotype Phenotype-shift over time Increased pain sensitivity MOH Inactivity Psychosocial factors, depression

Psychological treatments at DHC Groups of 8 patients, nine sessions, 2 hours each 1. Stress and tension, how to recognize and control 2. Biofeedback 3. Pain behaviour, pain accept 4. Cognitive restructuring 5. Feelings, how to handle 6. Thoughts, avoid negative circles 7. Communication 8. Problem solving methods 9. Summary, plan ahead

Important elements in a multidisciplinary headache team Medication Psychology Lifestyle and exercise Patient education Jensen et al Cephalalgia 2010,

Outcome in socalled refractory headache patients after treatment in a multidisciplinary center. Effect on the headache frequency (p<0.001) and reduction of abscence from woork with 60%(p<0.001) (N=1326) Days/month 30 25 20 15 10 Before After 5 0 Migræne TTH Cluster Other Total Jensen et al Cephalalgia 2010

Conclusions and perspectives In general, migraine and TTH has a good prognosis It is very rewarding to treat headache patients Stress and depression are important comorbidities to chronic TTH Depression and anxiety are pronounced coexisting Migraine and TTH, not in migraine alone Medication overuse is a very important and potentially preventable risk factor Increased focus on prevention of Chronification

Generally I'm very brave, only today I happen to have a headache!